Kiromic BioPharma (NASDAQ:KRBP) Shares Up 1.5%

Kiromic BioPharma, Inc. (NASDAQ:KRBP)’s stock price was up 1.5% during mid-day trading on Tuesday . The stock traded as high as $2.64 and last traded at $2.64. Approximately 355 shares changed hands during trading, a decline of 96% from the average daily volume of 8,360 shares. The stock had previously closed at $2.60.

Kiromic BioPharma Stock Performance

The firm’s 50 day simple moving average is $2.68 and its 200-day simple moving average is $1.42. The company has a market capitalization of $3.41 million, a price-to-earnings ratio of -0.18 and a beta of 2.00.

Kiromic BioPharma (NASDAQ:KRBP) last announced its earnings results on Monday, March 18th. The company reported ($4.16) earnings per share (EPS) for the quarter.

Kiromic BioPharma Company Profile

Kiromic BioPharma, Inc, an artificial intelligence driven allogeneic cell therapy company, engages in developing the multi-indication allogeneic T cell therapies that exploits the natural potency of the Gamma Delta T cell (GDT) to target solid tumors. The company develops ALEXIS-ISO-1, an allogeneic GDT therapy product that targets an isoform of mesothelin; and ALEXIS-PRO-1, an allogeneic GDT therapy product that targets PD-L1.